<DOC>
	<DOCNO>NCT02437669</DOCNO>
	<brief_summary>Intranasal hydromorphone show effective reduce acute pain adult . It previously study child , may viable option effectively safely reduce pain child administer analgesic intranasal route . This study prospective , open-label pilot study intranasal hydromorphone child moderate severe acute pain present pediatric emergency department . The investigator aim describe amount pain reduction associate intranasal hydromorphone , determine optimal dose intranasal hydromorphone associate clinically meaningful improvement acute pain .</brief_summary>
	<brief_title>Intranasal Hydromorphone Treatment Acute Pain Children : A Pilot Study .</brief_title>
	<detailed_description>Primary Aim : Determine change pain intensity child moderate severe pain receive intranasal hydromorphone . Secondary Aim ( ) : Describe incidence minor major adverse event associate intranasal hydromorphone child acute pain . The investigator assess patient 's pain baseline ( prior study drug administration ) , study drug administration : 5 minute , 15 minute , 30 minute , 45 minute , 60 minute , every 30 minute thereafter 6 hour ; administration non-protocolized rescue medication administration ( i.e . administer first two rescue dos IN hydromorphone ) ; discharge emergency department ( whichever come first ) . The investigator evaluate qualitative improvement pain intensity 15- 30-minutes study drug administration . If improvement , worsen pain intensity , assessment , additional rescue dose rescue dose intranasal hydromorphone administer . After 60 minute , treat physician may administer additional rescue medication discretion treat child 's pain . The patient assess minor major adverse event duration study .</detailed_description>
	<mesh_term>Acute Pain</mesh_term>
	<mesh_term>Hydromorphone</mesh_term>
	<criteria>Age 4 17 year old , inclusive Moderate severe pain ( i.e . FPSR vNRS score 4 ) Requires parenteral opioid analgesic treat pain , decide treat physician Allergy know contraindication receive opioids Receipt opioid benzodiazepine within precede 6 hour Presence intranasal obstruction clear readily Can speak English Spanish Patient unlikely able complete selfreport measure pain questionnaire Known liver kidney problem Currently critically ill Chronic pain condition ( e.g . sickle cell disease , fibromyalgia )</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Intranasal</keyword>
	<keyword>Hydromorphone</keyword>
	<keyword>Pediatric</keyword>
	<keyword>Emergency department</keyword>
</DOC>